Search - tctmd.com

Displaying 161 - 174 of 174

Sort: Relevancy | Date

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Daily News

上游依替巴肽疗法与PCI患者获得更好的结果相关

Yael L. Maxwell

August 19, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

L.A. McKeown

April 19, 2013

News Conference News ACC 2013

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Yael L. Maxwell

March 09, 2013

News Daily News

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Caitlin E. Cox

September 20, 2012

News Daily News

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

July 03, 2012

News Daily News

Right Coronary CTO Forecasts Mortality After Left Main PCI

Leah Lawrence

March 06, 2012

News Daily News

Similar Mortality Rates Seen in Men and Women with NSTE ACS

L.A. McKeown

January 26, 2012

Presentation

Influence of Gender on Long-term Mortality in Patients Presenting with NSTE ACS Undergoing PCI

Presenter: D. Kumbhani

January 26, 2012

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Conference News

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

September 01, 2011

News Daily News

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

June 15, 2011

News Daily News

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Jason Kahn

May 05, 2011

Advertisement

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

上游依替巴肽疗法与PCI患者获得更好的结果相关

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

Right Coronary CTO Forecasts Mortality After Left Main PCI

Similar Mortality Rates Seen in Men and Women with NSTE ACS

Influence of Gender on Long-term Mortality in Patients Presenting with NSTE ACS Undergoing PCI

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content